CDC Logo Tuberculosis Information CD-ROM   Image of people
jump over main navigation bar to content area
TB Guidelines
Surveillance Reports
Slide Sets
TB-Related MMWRs and Reports
Education/Training Materials
Ordering Information


U.S. Department of Health and Human Services

jump over right navigation bar
TB Notes 2, 2007
Director's Letter
Highlights from State and Local Programs
  Successful Collaborations by New England TB Prevention and Control Programs
World TB Day 2007
  First Annual TB Awareness Walk
  TB and HIV Analogy
  From Us to You
Nursing Update
  Judy Gibson, BSN, MSN, Receives Chief Nurse Officer Award
TB Education and Training Network Updates
  Member Highlight
  Cultural Competency Workgroup: Special Topic Discussion on “The Culture of Substance Users”
Communications, Education, and Behavioral Studies Branch Update
  New Additions to
Clinical and Health Systems Research Branch Updates
  MDR TB and XDR TB Clinical Trials Design Working Group Formed
  The Long Road to a Shorter, Stronger, Safer Cure for TB – How to Get There Faster
International Research and Programs Branch Update
  Building the Capacity of Health Care Workers from the Former Soviet Union on TB/HIV Surveillance Activities
Surveillance, Epidemiology, and Outbreak Investigations Branch Updates
  RVCT Revision
  10th Semiannual Meeting of the TB Epidemiologic Studies Consortium
New CDC Publications
Personnel Notes
Calendar of Events
Return to Table of Contents

TB Notes Newsletter

No. 2, 2007


Peter Cegielski, MD, of DTBE’s International Research and Programs Branch received the 2007 Brachman Award on April 19, 2007, at the 56th Epidemic Intelligence Service (EIS) Conference for excellence in teaching epidemiology to EIS Officers. Peter was selected to receive this award by the EIS Class of 2005, which just completed its 2-year training. Peter was the co-recipient of this year's award along with Dr. Joshua Mott of the National Center for Immunization and Respiratory Diseases. Congratulations, Peter!

Al Forbes is returning to DTBE in Atlanta in June as a TB Program Consultant. He has been serving in the Miami, Florida, public health advisor position since September 18, 2005. Al began his CDC career in 1993 as a public health associate with the New York City (NYC) Department of Health Bureau of Tuberculosis Control. His assignment to NYC provided him with a broad understanding of public health and knowledge about programmatic issues and clinical services. In 1997, he was promoted and transferred to the New Jersey Department of Health and Senior Services Tuberculosis Program, where he served as the assistant to the senior public health advisor. While there, he provided consultation and technical assistance in program planning, coordination, operations, training, administration, and evaluation. In 1999, Al was selected as the assistant project manager for the Tuberculosis Information Management System (TIMS). In this position he provided technical assistance and training to TIMS users nationwide. He worked closely with the Surveillance Branch regarding the interface of TB surveillance data and with the Field Services and Evaluation Branch (FSEB) program consultants regarding resource needs and management problems. In 2001, he became a program consultant and assumed the duties of overseeing DTBE’s COAG activities and providing guidance and consultation to the Mid-Atlantic region. Welcome back, Al!

Judy Gibson, BSN, MSN, Nurse Consultant, Field Services and Evaluation Branch, DTBE, was a recipient of the Chief Nurse Officer Award. Please see the related article in this issue.

Regina Gore is being reassigned to DTBE in Atlanta as a TB program consultant in May. Since January 2003, she has been the special projects coordinator for the TB Control Program in Frankfort, Kentucky. Regina started her CDC career in 1989 as a public health associate assigned to the Fulton County Sexually Transmitted Disease (STD) control program in Atlanta, Georgia. She also held STD positions in Tampa, Florida, from June 1990 until January 1992, when she was promoted to a first-line supervisor position in Kansas City, Missouri. After resigning from CDC in 1994, she moved to Miami, Florida, where she became the program coordinator for a mobile HIV testing team. In September 1998, she relocated to Atlanta, Georgia, and became a research interviewer for Emory University, providing STD services for clients enrolled in a program called Project Prevent, which provided assistance for expectant mothers with substance abuse problems. She was rehired by CDC/DTBE in January 2000 and was assigned to the Palm Beach County, Delray Beach Health Department, TB Program from 2000 to 2003. Her duties in Delray Beach included providing DOT and DOPT therapy, presenting cases in chart review with the regional consultant, and conducting contact investigations and case management.

Darryl Hardge has been selected for the senior public health advisor position for the state of Pennsylvania. His official start date in Harrisburg was March 19, 2007. Darryl most recently served as the Program Director for the Washington, DC, TB Control Program. During his tenure there, Darryl made significant progress in strengthening and modernizing the TB control program through the recruitment of key staff and by planning and coordinating the renovations for a new, state-of-the-art TB clinic, to open in 2007. In addition, he completed a temporary duty assignment assisting the Louisiana TB program with recovery efforts from hurricanes Rita and Katrina.

Darryl came to work for CDC in May 1991 as a public health associate in the Division of Sexually Transmitted Disease Prevention, and was assigned to the Division's Disease Intervention Specialist (DIS) training center in Decatur, Georgia. In 1992 Darryl was reassigned to Milwaukee, Wisconsin, as a DIS working in high-morbidity areas. From January until February 1996, he had a temporary duty assignment in Baltimore, assisting the STD program with an outbreak of syphilis and HIV. In 1996 Darryl became a lead worker in Milwaukee, supervising six DIS staff. In October 1997, he joined DTBE and was assigned with promotion to the state of Louisiana TB program. In November 1998, Darryl assumed a number of the senior PHA duties on an interim basis for the Louisiana TB Program and received a promotion for these efforts. In May 1999, he was assigned to the Baltimore TB program as the program manager. During this assignment, Darryl led the program through two large and complex TB outbreaks. During his tenure in Baltimore, Darryl participated on a temporary duty assignment in Washington, DC, helping with CDC's effort to respond to the anthrax attacks. In 2002, Darryl took a position as a Program Consultant with DTBE at CDC headquarters and was responsible for providing consultation and assistance to TB control programs in Missouri, Kansas, Iowa, Nebraska, South Dakota, North Dakota, and Minnesota. FSEB thanks Darryl for an excellent duty assignment in Washington, DC, and congratulates him on his new assignment to Pennsylvania.

Ken Johnson, formerly a DTBE public health advisor (PHA), left the division and joined CDC’s Division of Global Public Health & Capacity Development In March 2007. Ken began working with CDC in 1990 as a PHA with the Division of Sexually Transmitted Disease in Chicago, Illinois, working with the Chicago Department of Health and then working with the North Carolina State Department of Health. Subsequently he transitioned to and began working with the Division of Tuberculosis Elimination in New York City and the Fulton County Department of Health and Wellness. He has worked at various levels in public health management, including his most recent position as the TB Program Coordinator in Fulton County, Georgia. While working in DTBE, he was also deployed to various locations for temporary duty assignments including Brazil, New Orleans after Hurricane Katrina, and most recently Mississippi.

Heather R. Morrow-Almeida, MPH, completed her assignment with DTBE on April 13, 2007. This was her first assignment as a Public Health Prevention Service Fellow. While in DTBE’s Field Services and Evaluation Branch, she worked on several projects, focusing primarily on evaluation with the Program Evaluation team. She collaborated with members of the Program Evaluation team and the Surveillance team (SEOIB) on the development and pilot testing of the National Tuberculosis Indicators Project (NTIP), a monitoring tool consisting of indicator reports that match national TB program objectives. This tool will help TB control programs monitor their progress in meeting the national objectives for TB and will inform future directions for program evaluation. She also worked on several documents that complement the evaluation toolkit materials developed by the Program Evaluation team for state partners. These documents include profiles of TB indicators focused on TB program priorities, and a model evaluation plan to be refined into a case study.

Heather’s next assignment is with the Associate Director for Science in the National Center for Environmental Health. She will be working on advancements in the field of health and the built environment. Heather truly enjoyed her time working in DTBE, and leaves with tremendous respect for the hardworking and dedicated individuals she met in the division. She is secretly plotting her return to the division, and hopes it won’t take long.

Charles Wells, MD, Chief of DTBE’s International Research and Programs Branch (IRPB), is leaving CDC for a research position in private industry. Charles obtained his medical degree from the University of North Carolina, Chapel Hill, completed his postgraduate training at Emory University School of Medicine, and is board certified in internal medicine and infectious diseases. From 1995 until 1997 he served as an Epidemic Intelligence Service (EIS) officer in DTBE's then-named International Activity, where he helped define the epidemiology of TB in foreign-born persons and identify risk factors associated with active TB in recent immigrants and refugees. He then completed an infectious disease fellowship at Emory University School of Medicine in Atlanta, Georgia (1997-1998). After completing the fellowship, he held the position of Associate Director, Medical Affairs with PathoGenesis Corporation in Seattle (1998-1999). In this role, he led clinical research activities, specifically being responsible for the design and medical monitoring of phase 1, 2, and 3 novel anti-TB drugs. In November 1999 he was again recruited to join DTBE's International Activity, this time as a Medical Epidemiologist. In that position, Charles served as the project officer in the development and implementation of a model center for multidrug-resistant (MDR) TB treatment in Latvia, and was instrumental in implementing operations research activities in Russia and Peru. In 2000, Charles was selected as the Chief of the branch to replace Dr. Nancy Binkin, who was retiring. As Chief, Charles leads a branch of medical epidemiologists, public health advisors, fellows, research nurses, and administrative support staff in Atlanta, Botswana, Brazil, India, Paris, and Thailand, with a current total of 78 in the branch. He has supervised projects in Russia, Ukraine, Latvia, Estonia, Lithuania, Romania, Mexico, Peru, El Salvador, Brazil, Guyana, Haiti, South Africa, Botswana, Ethiopia, Mozambique, Rwanda, India, Thailand, Cambodia, Vietnam, and Philippines. In this coordinating role, Charles was responsible for developing and maintaining crucial political and financial relationships with global partners, donors, and individual countries.

In addition to leading the unit in providing technical assistance and supportive research for TB control in more than 20 countries, Charles has also served on several important international committees. From September 2000 to January 2005, he served as the CDC alternate for the World Health Organization (WHO) Green Light Committee (GLC). The GLC is a 6-member panel drawn from leading international technical agencies coordinated by WHO to facilitate access by resource-limited countries to lower-priced second-line drugs for treatment of MDR TB. The GLC serves as a protective mechanism to prevent development of widespread resistance to second-line drugs for TB treatment. From January 2001 to 2007, he served as a board member of the TB Coalition for Technical Assistance (TBCTA). The coalition coordinates USAID resources totaling $150 million for provision of technical assistance to developing countries with a high TB burden. Also, from June 2004 to 2007, Charles was a member of the U.S. government interagency TB/HIV technical working group for PEPFAR. This group provides technical support and input to the Office of the Global AIDS Coordinator related to the screening, diagnosis, treatment, and management of HIV-associated TB within the framework of the PEPFAR initiative. In addition to his accomplishments as a scientist, Charles embodies the caring, dedicated, and visionary spirit that sets our division apart from others and which enables him every year to recruit outstanding new EIS officers and permanent staff to the division in pursuit of global TB elimination. We wish Charles all the best in his new position, and will miss his dynamic leadership.


Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination -

Please send comments/suggestions/requests to:, or to
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333